5-6-circle

2-circle
4-circle

Premier, Inc.’s TheraDoc® named top clinical surveillance solution by KLAS

By | News | No Comments

KLAS’s 2014 Best in KLAS Awards: Software & Services report incorporates feedback from healthcare organizations across the country on which healthcare IT vendors perform the best. TheraDoc was named a Category Leader for Clinical Decision Support –Surveillance for helping healthcare professionals deliver better patient care.

“Patient safety is the number one priority for hospitals. It’s also an ever-evolving area, and clinicians are constantly challenged to not only protect patients but also adapt to new public reporting and regulatory mandates,” said Keith J. Figlioli, senior vice president of healthcare informatics, Premier. “TheraDoc is a leading solution that gives the time it takes to deal with these challenges back to clinicians so they can focus on providing high-quality care.”

Read More

Premier, Inc. continues growth trajectory with acquisition of Hospira’s TheraDoc

By | News | No Comments

Premier, Inc. (NASDAQ: PINC) has reached a definitive agreement to acquire TheraDoc, a market leading provider of clinical surveillance software, for $117 million in cash, subject to potential purchase price adjustments regarding TheraDoc’s actual working capital, cash and indebtedness at closing. The transaction is expected to close in Premier’s fiscal 2015 first quarter ending September 30, 2014, subject to customary closing conditions.

TheraDoc is a wholly-owned subsidiary of Hospira (NYSE: HSP). Premier’s board of directors unanimously approved the transaction, and applicable antitrust approvals have already been obtained. Based on the trailing twelve months operating earnings provided by TheraDoc, the $117 million represents a purchase price multiple in the 10-11 times range.

Read More

Article in Infection Control and Hospital Epidemiology concludes TheraDoc alerting combined with antimicrobial stewardship intervention has multiple postive effects

By | News | No Comments

The article illustrates how TheraDoc’s active alerting was used in combination with antimicrobial stewardship interventions on patients with gram-negative bacteremia. The study discussed in this article was a quasi-experimental retrospective cohort study conducted at three hospitals within Detroit Medical Center, with a combined 1,100 beds. Data resulting from active alerting of a positive blood culture coupled with stewardship intervention was compiled during 2010–2011 and compared to data from patients who received no formalized stewardship intervention during 2009.

Read More